Clinical and pathologic features of secondary acute promyelocytic leukemia

Amy S Duffield, Joseph Aoki, Mark J Levis, Kathleen Cowan, Christopher Gocke, Kathleen Burns, Michael J Borowitz, Milena Vuica-Ross

Research output: Contribution to journalArticle

Abstract

Acute promyelocytic leukemia (APL) is a relatively common form of acute myeloid leukemia (AML) that has an excellent prognosis. In contrast, secondary acute myeloid leukemias, including therapy-related AML and AML with myelodysplasia-related changes, have a relatively poor prognosis. We identified 9 cases of APL at our institution in which there was a history of chemotherapy, radiotherapy, chronic immunosuppression, or antecedent myelodysplastic syndrome. The clinical and pathologic findings in these cases of secondary APL were compared with the clinical and pathologic findings in cases of de novo APL. We found that secondary and de novo APL had abnormal promyelocytes with similar morphologic and immunophenotypic features, comparable cytogenetic findings, comparable rates of FMS-like tyrosine kinase mutations, and similar rates of recurrent disease and death. These data suggest that secondary APL is similar to de novo APL and, thus, should be considered distinct from other secondary acute myeloid neoplasms. Copyright

Original languageEnglish (US)
Pages (from-to)395-402
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume137
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Acute Promyelocytic Leukemia
Acute Myeloid Leukemia
Granulocyte Precursor Cells
Myelodysplastic Syndromes
Mutation Rate
Cytogenetics
Protein-Tyrosine Kinases
Immunosuppression
Radiotherapy
Drug Therapy

Keywords

  • Acute myeloid leukemia with myelodysplasia-related changes
  • Acute promyelocytic leukemia
  • APL
  • Flow cytometry
  • Therapy-related acute myeloid leukemia
  • Therapy-related myeloid neoplasm

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Clinical and pathologic features of secondary acute promyelocytic leukemia. / Duffield, Amy S; Aoki, Joseph; Levis, Mark J; Cowan, Kathleen; Gocke, Christopher; Burns, Kathleen; Borowitz, Michael J; Vuica-Ross, Milena.

In: American Journal of Clinical Pathology, Vol. 137, No. 3, 03.2012, p. 395-402.

Research output: Contribution to journalArticle

@article{0926c3d73ee9490496a6f9f3a447447c,
title = "Clinical and pathologic features of secondary acute promyelocytic leukemia",
abstract = "Acute promyelocytic leukemia (APL) is a relatively common form of acute myeloid leukemia (AML) that has an excellent prognosis. In contrast, secondary acute myeloid leukemias, including therapy-related AML and AML with myelodysplasia-related changes, have a relatively poor prognosis. We identified 9 cases of APL at our institution in which there was a history of chemotherapy, radiotherapy, chronic immunosuppression, or antecedent myelodysplastic syndrome. The clinical and pathologic findings in these cases of secondary APL were compared with the clinical and pathologic findings in cases of de novo APL. We found that secondary and de novo APL had abnormal promyelocytes with similar morphologic and immunophenotypic features, comparable cytogenetic findings, comparable rates of FMS-like tyrosine kinase mutations, and similar rates of recurrent disease and death. These data suggest that secondary APL is similar to de novo APL and, thus, should be considered distinct from other secondary acute myeloid neoplasms. Copyright",
keywords = "Acute myeloid leukemia with myelodysplasia-related changes, Acute promyelocytic leukemia, APL, Flow cytometry, Therapy-related acute myeloid leukemia, Therapy-related myeloid neoplasm",
author = "Duffield, {Amy S} and Joseph Aoki and Levis, {Mark J} and Kathleen Cowan and Christopher Gocke and Kathleen Burns and Borowitz, {Michael J} and Milena Vuica-Ross",
year = "2012",
month = "3",
doi = "10.1309/AJCPE0MV0YTWLUUE",
language = "English (US)",
volume = "137",
pages = "395--402",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "3",

}

TY - JOUR

T1 - Clinical and pathologic features of secondary acute promyelocytic leukemia

AU - Duffield, Amy S

AU - Aoki, Joseph

AU - Levis, Mark J

AU - Cowan, Kathleen

AU - Gocke, Christopher

AU - Burns, Kathleen

AU - Borowitz, Michael J

AU - Vuica-Ross, Milena

PY - 2012/3

Y1 - 2012/3

N2 - Acute promyelocytic leukemia (APL) is a relatively common form of acute myeloid leukemia (AML) that has an excellent prognosis. In contrast, secondary acute myeloid leukemias, including therapy-related AML and AML with myelodysplasia-related changes, have a relatively poor prognosis. We identified 9 cases of APL at our institution in which there was a history of chemotherapy, radiotherapy, chronic immunosuppression, or antecedent myelodysplastic syndrome. The clinical and pathologic findings in these cases of secondary APL were compared with the clinical and pathologic findings in cases of de novo APL. We found that secondary and de novo APL had abnormal promyelocytes with similar morphologic and immunophenotypic features, comparable cytogenetic findings, comparable rates of FMS-like tyrosine kinase mutations, and similar rates of recurrent disease and death. These data suggest that secondary APL is similar to de novo APL and, thus, should be considered distinct from other secondary acute myeloid neoplasms. Copyright

AB - Acute promyelocytic leukemia (APL) is a relatively common form of acute myeloid leukemia (AML) that has an excellent prognosis. In contrast, secondary acute myeloid leukemias, including therapy-related AML and AML with myelodysplasia-related changes, have a relatively poor prognosis. We identified 9 cases of APL at our institution in which there was a history of chemotherapy, radiotherapy, chronic immunosuppression, or antecedent myelodysplastic syndrome. The clinical and pathologic findings in these cases of secondary APL were compared with the clinical and pathologic findings in cases of de novo APL. We found that secondary and de novo APL had abnormal promyelocytes with similar morphologic and immunophenotypic features, comparable cytogenetic findings, comparable rates of FMS-like tyrosine kinase mutations, and similar rates of recurrent disease and death. These data suggest that secondary APL is similar to de novo APL and, thus, should be considered distinct from other secondary acute myeloid neoplasms. Copyright

KW - Acute myeloid leukemia with myelodysplasia-related changes

KW - Acute promyelocytic leukemia

KW - APL

KW - Flow cytometry

KW - Therapy-related acute myeloid leukemia

KW - Therapy-related myeloid neoplasm

UR - http://www.scopus.com/inward/record.url?scp=84859237502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859237502&partnerID=8YFLogxK

U2 - 10.1309/AJCPE0MV0YTWLUUE

DO - 10.1309/AJCPE0MV0YTWLUUE

M3 - Article

C2 - 22338051

AN - SCOPUS:84859237502

VL - 137

SP - 395

EP - 402

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 3

ER -